1. Home
  2. PSTX vs TTGT Comparison

PSTX vs TTGT Comparison

Compare PSTX & TTGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTX
  • TTGT
  • Stock Information
  • Founded
  • PSTX 2014
  • TTGT 1999
  • Country
  • PSTX United States
  • TTGT United States
  • Employees
  • PSTX N/A
  • TTGT N/A
  • Industry
  • PSTX Biotechnology: Biological Products (No Diagnostic Substances)
  • TTGT Telecommunications Equipment
  • Sector
  • PSTX Health Care
  • TTGT Telecommunications
  • Exchange
  • PSTX Nasdaq
  • TTGT Nasdaq
  • Market Cap
  • PSTX 909.4M
  • TTGT 810.0M
  • IPO Year
  • PSTX 2020
  • TTGT 2007
  • Fundamental
  • Price
  • PSTX $9.45
  • TTGT $19.55
  • Analyst Decision
  • PSTX Hold
  • TTGT Strong Buy
  • Analyst Count
  • PSTX 3
  • TTGT 6
  • Target Price
  • PSTX $9.00
  • TTGT $38.17
  • AVG Volume (30 Days)
  • PSTX 2.7M
  • TTGT 301.5K
  • Earning Date
  • PSTX 11-07-2024
  • TTGT 02-05-2025
  • Dividend Yield
  • PSTX N/A
  • TTGT N/A
  • EPS Growth
  • PSTX N/A
  • TTGT N/A
  • EPS
  • PSTX N/A
  • TTGT N/A
  • Revenue
  • PSTX $150,858,000.00
  • TTGT $260,750,999.00
  • Revenue This Year
  • PSTX $131.92
  • TTGT $1.57
  • Revenue Next Year
  • PSTX N/A
  • TTGT $6.46
  • P/E Ratio
  • PSTX N/A
  • TTGT N/A
  • Revenue Growth
  • PSTX 203.18
  • TTGT 31.84
  • 52 Week Low
  • PSTX $1.87
  • TTGT $19.53
  • 52 Week High
  • PSTX $9.58
  • TTGT $41.93
  • Technical
  • Relative Strength Index (RSI)
  • PSTX 86.05
  • TTGT 27.49
  • Support Level
  • PSTX $9.35
  • TTGT $19.57
  • Resistance Level
  • PSTX $9.56
  • TTGT $21.48
  • Average True Range (ATR)
  • PSTX 0.10
  • TTGT 2.42
  • MACD
  • PSTX -0.17
  • TTGT -0.60
  • Stochastic Oscillator
  • PSTX 56.67
  • TTGT 0.15

About PSTX Poseida Therapeutics Inc.

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

About TTGT TechTarget Inc.

TechTarget Inc is a data, software and analytics leader for purchase intent-driven marketing and sales data which delivers business impact for business-to-business (B2B) companies. The company solutions are designed to enable B2B technology companies to identify, reach, and influence key enterprise technology decision makers faster and with higher efficacy. Geographically, it derives a majority of its revenue from North America. Its products and services intended to improve information technology vendors abilities to impact targeted audiences for business growth using targeting, first-party analytics and data services complemented with customized marketing programs that integrate content creation, demand generation, brand marketing, and other advertising techniques.

Share on Social Networks: